Markel Group Inc. increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA – Free Report) by 7.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 80,680 shares of the company’s stock after purchasing an additional 5,467 shares during the period. Markel Group Inc.’s holdings in HCA Healthcare were worth $37,666,000 at the end of the most recent quarter.
Other institutional investors have also modified their holdings of the company. Palisade Asset Management LLC bought a new position in shares of HCA Healthcare during the 3rd quarter valued at about $26,000. Holos Integrated Wealth LLC bought a new position in shares of HCA Healthcare during the 4th quarter valued at about $29,000. Ares Financial Consulting LLC bought a new stake in HCA Healthcare in the 4th quarter valued at approximately $31,000. JPL Wealth Management LLC bought a new stake in HCA Healthcare in the 3rd quarter valued at approximately $33,000. Finally, Aventura Private Wealth LLC bought a new stake in HCA Healthcare in the 4th quarter valued at approximately $34,000. Institutional investors own 62.73% of the company’s stock.
Analysts Set New Price Targets
Several equities research analysts have commented on HCA shares. Cantor Fitzgerald restated an “overweight” rating on shares of HCA Healthcare in a research note on Wednesday, March 4th. Truist Financial cut their target price on HCA Healthcare from $546.00 to $535.00 and set a “buy” rating on the stock in a research note on Monday, April 27th. Sanford C. Bernstein dropped their price objective on HCA Healthcare from $541.00 to $503.00 and set a “market perform” rating on the stock in a research note on Tuesday, April 28th. JPMorgan Chase & Co. lowered their target price on shares of HCA Healthcare from $535.00 to $490.00 and set a “neutral” rating on the stock in a report on Tuesday. Finally, Mizuho boosted their target price on shares of HCA Healthcare from $540.00 to $585.00 and gave the stock an “outperform” rating in a report on Wednesday, February 25th. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $515.77.
HCA Healthcare Trading Up 0.5%
HCA opened at $394.40 on Friday. HCA Healthcare, Inc. has a 1-year low of $330.00 and a 1-year high of $556.52. The stock’s fifty day simple moving average is $465.16 and its 200 day simple moving average is $483.61. The stock has a market cap of $87.49 billion, a PE ratio of 13.56, a price-to-earnings-growth ratio of 1.24 and a beta of 1.18.
HCA Healthcare (NYSE:HCA – Get Free Report) last posted its quarterly earnings results on Friday, April 24th. The company reported $7.15 earnings per share for the quarter, missing analysts’ consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same quarter last year, the company posted $6.45 EPS. The firm’s revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 30.07 earnings per share for the current year.
HCA Healthcare Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Stockholders of record on Tuesday, June 16th will be issued a dividend of $0.78 per share. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Tuesday, June 16th. HCA Healthcare’s dividend payout ratio is 10.73%.
HCA Healthcare Company Profile
HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.
The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.
See Also
- Five stocks we like better than HCA Healthcare
- SpaceX IPO: Opportunity? Or the Ultimate Hype Trade?
- CAVA Group’s Stock Looks Delicious After Strong Earnings
- Lowe’s Finds Support at $215 After Q1 Earnings Sell-Off
- Deere Beats Q2 Estimates, But Ag Weakness Weighs on Outlook
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA – Free Report).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
